CTI BioPharma: 3Q Earnings Snapshot

November 4, 2019 GMT

SEATTLE (AP) _ CTI BioPharma Corp. (CTIC) on Monday reported a loss of $10 million in its third quarter.

The Seattle-based company said it had a loss of 17 cents per share.

The biotechnology company posted revenue of $2.3 million in the period.

In the final minutes of trading on Monday, the company’s shares hit 80 cents. A year ago, they were trading at $1.80.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTIC at https://www.zacks.com/ap/CTIC